dimethyldithiocarbamate has been researched along with tetradecanoylphorbol acetate in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gruntmeir, J; Irons, RD; Pyatt, DW; Stillman, WS | 1 |
1 other study(ies) available for dimethyldithiocarbamate and tetradecanoylphorbol acetate
| Article | Year |
|---|---|
Dimethyldithiocarbamate inhibits in vitro activation of primary human CD4+ T lymphocytes.
Topics: CD4-Positive T-Lymphocytes; Dimethyldithiocarbamate; Flow Cytometry; Humans; Immunosuppressive Agents; Interleukin-2; Lymphocyte Activation; NF-kappa B; Receptors, Interleukin-2; Tetradecanoylphorbol Acetate; Tumor Necrosis Factor-alpha | 1998 |